Ayman Elbadawi

Ayman Elbadawi practices at John Sealy Hospital in Galveston, Texas, part of The University of Texas System.

Ayman Elbadawi's NPI, 1841669587, was assigned on September 23, 2015. Ayman Elbadawi graduated from University of Ain Shams, Abbasia FOM in 2010. Ayman Elbadawi holds Texas license U3832.

Ayman Elbadawi's primary practice is John Sealy Hospital, at 301 University Boulevard, Galveston, TX 77555 in Galveston County. The practice phone is (409) 772-1011.

Ayman Elbadawi's primary practice is John Sealy Hospital in Galveston, Texas, part of The University of Texas System. Ayman Elbadawi is also affiliated with Baylor St. Luke's Medical Center. The medical group on file is UTMB Faculty Group Practice. Dmand AI also links Ayman Elbadawi to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ayman Elbadawi practices, 3 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Ayman Elbadawi's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Ayman Elbadawi is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Ayman Elbadawi's licenses on file in 2 states: Texas and Ohio.

Dmand AI lists angioplasty among the conditions Ayman Elbadawi treats.

CMS data shows 1,320 Medicare services from Ayman Elbadawi across 19 procedure codes in 2024, for 454 Medicare patients. Medicare paid $60,601 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 454 Medicare patients who saw Ayman Elbadawi in 2024. The largest group is 65 to 74, with 180 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ayman Elbadawi's median patient age at 66, with 54% women.

In 2024, Ayman Elbadawi wrote 978 Medicare Part D claims for 213 patients. 85% of them were for generic drugs. CMS names the drug for 869 of them, across 21 drugs with 11 or more claims each, at $80,182 in total drug cost. In 2018, CMS named 67 claims across 5 drugs.

Ayman Elbadawi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 13 procedures of coronary angioplasty and stenting by Ayman Elbadawi, more than 35% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 250 papers to Ayman Elbadawi, published from 2015 to 2025. 2021 was the busiest year, with 37. The most frequent topics are Hospital Mortality, Percutaneous Coronary Intervention and Transcatheter Aortic Valve Replacement. Ayman Elbadawi has published most often in Am J Cardiol. Ayman Elbadawi's most frequent co-authors are Islam Youssef Ahmed Elgendy, MD, Gbolahan O. Ogunbayo, MD and Mohamed A. Omer, MD.

CMS Open Payments shows 164 general payments to Ayman Elbadawi from 19 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 52% of the total. Edwards Lifesciences Corporation paid the most, $4,562.

Ayman Elbadawi graduated from University of Ain Shams, Abbasia FOM in 2010.

Ayman Elbadawi is in network with 20 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.